CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $129,609 | -15.1% | 137,560 | +1.8% | 0.06% | -10.6% |
| Q2 2023 | $152,674 | -12.3% | 135,110 | -1.4% | 0.07% | -13.2% |
| Q1 2023 | $174,066 | +43.3% | 137,060 | -14.7% | 0.08% | +49.0% |
| Q4 2022 | $121,469 | +11.4% | 160,610 | -7.8% | 0.05% | +4.1% |
| Q3 2022 | $109,000 | +23.9% | 174,175 | -3.8% | 0.05% | +28.9% |
| Q2 2022 | $88,000 | -26.1% | 181,075 | +25.9% | 0.04% | -32.1% |
| Q1 2022 | $119,000 | -15.0% | 143,850 | +30.2% | 0.06% | -17.6% |
| Q4 2021 | $140,000 | +4.5% | 110,525 | +83.9% | 0.07% | -2.9% |
| Q3 2021 | $134,000 | +27.6% | 60,100 | +15.4% | 0.07% | +22.8% |
| Q2 2021 | $105,000 | -16.7% | 52,100 | +9.6% | 0.06% | -24.0% |
| Q1 2021 | $126,000 | +20.0% | 47,550 | -9.0% | 0.08% | +7.1% |
| Q4 2020 | $105,000 | +15.4% | 52,252 | +63.5% | 0.07% | -1.4% |
| Q3 2020 | $91,000 | – | 31,959 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |